« Return to News | Ethics/Regulatory

Irish-based pharma firms now have stricter marketing code

Friday, January 20, 2012 10:46 AM

Pharmaceutical companies in Ireland may no longer use well-known entertainment or other leisure activity venues to promote their products to health professionals, new guidelines have stated.

According to a report in The Irish Times, the updated code of marketing practice for the industry has strict criteria for promoting new drugs to health professionals. Corporate activities involving sporting, entertainment or social events must not be extended to healthcare professionals. And promotional meetings may not be held to coincide with sporting or entertainment events.

The code also states companies should not hold events abroad unless absolutely necessary and foreign professionals are also attending. Travel expenses are not to be paid for spouses or partners unless those persons are also healthcare professionals involved in the field. Companies can, however, provide corporate hospitality if it is a bona fide charity event.

It states health professionals should not receive more than four medical samples of a particular new medicine per year. Sampling cannot extend to any mind-altering drugs such as sedatives or anti-depressants. And pharmaceutical companies must declare in clear language any support they give to patients’ associations.

The guidelines are to ensure Irish-based pharmaceutical companies comply with the updated European Federation of Pharmaceutical Industries and Associations regulations.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.